about
The role of the substantia nigra pars compacta in regulating sleep patterns in ratsApoptosis in ischemic heart diseaseInduction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptorsEndogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism.Shear stress attenuates apoptosis due to TNFα, oxidative stress, and serum depletion via death-associated protein kinase (DAPK) expression.Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling.Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.The potential role of vascular endothelial growth factor in the central nervous system.The Role of (99m)Tc-Annexin V Apoptosis Scintigraphy in Visualizing Early Stage Glucocorticoid-Induced Femoral Head Osteonecrosis in the Rabbit.Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons.Treadmill exercise alleviates short-term memory impairment in 6-hydroxydopamine-induced Parkinson's rats.Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease.Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.Corals and their potential applications to integrative medicine.Protective Mechanisms of Flavonoids in Parkinson's Disease.Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.Myocardial apoptosis in heart disease: does the emperor have clothes?Protein kinase C delta mediated cytotoxicity of 6-Hydroxydopamine via sustained extracellular signal-regulated kinase 1/2 activation in PC12 cells.Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat.Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson's model: a promising candidate for the treatment of Parkinson's disease.Bacterial melanin in rat models of Parkinson's disease: a potential neuroprotective strategyViral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat.A review of genome-wide transcriptomics studies in Parkinson's disease.Effects of Agaricus brasiliensis mushroom in Walker-256 tumor-bearing rats.Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.2,5-hexanedione induces bone marrow mesenchymal stem cell apoptosis via inhibition of Akt/Bad signal pathway.Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.The choroid and lamina cribrosa is affected in patients with Parkinson's disease: enhanced depth imaging optical coherence tomography study.Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study
P2860
Q21562323-87AB2E46-7FFC-423B-B32F-8ECF89504953Q33623568-CC1AE721-2846-422F-A431-9B8BE8EC9705Q33915563-DACEC2EB-60BE-4AEB-A2C4-D59B6AE72B40Q34516390-1715A3FC-55E5-4DED-AA21-2CD5CCEBF6B1Q35609135-2220B05C-938E-4264-B514-0F514D051A6CQ35886625-796916A1-3273-428D-95C6-57E8738E900AQ35919348-FD87AF49-5280-44C1-9EF5-2CBEDAE0BE5FQ35939261-2296FAD6-959E-4B5D-90C5-54F72FE00E0AQ36632876-40FF60DB-5191-4ED0-8012-D666ABE88AB0Q37014379-2C18E999-36AC-43DC-AA83-B462E9E4DFD2Q37332384-9263CCB0-BF50-4BB4-816E-594888123B7EQ37578490-57B6AF37-FD52-418D-ABA0-564C0CAB551FQ37613043-E036A9FA-7961-4550-8262-B27307B1FA2FQ37686766-BB3C31D4-32F6-47B6-ACE3-CAF0079CC04AQ38635687-16E24979-F00A-431A-BADF-B8AD07B67482Q38664598-1DF99D0D-A759-44E6-A8A3-E22481CAA1F9Q38797807-84E1FFEC-6C79-405F-9A4B-A6B9BA9D3E3EQ39084131-632EF257-9C21-47E6-870D-9961ABB30BE5Q39121710-535E6757-9914-40E0-83C7-2F64B4186C9CQ39179414-799B4AFE-07BA-4AE2-9871-8D0395D69071Q39205347-64EB108C-3F6D-4500-992A-782EB6E58EE3Q39436892-B1E53B8D-4BE6-4290-894A-17E6BD4BB79FQ39491010-B30563A9-E016-4A98-B0D3-5BF361FFAEC2Q42127205-0EEE6569-338B-418C-A77A-11FC5EB8D49AQ42778276-C206346B-295D-4B24-8B67-ADBD6C1AED31Q43174373-3E5DF634-CAD6-4662-8696-211066D0FDB3Q46958208-8F200535-B20A-4FCE-9EEB-41E8EEE7B103Q47868304-81F19FE5-2466-48BD-B226-562600C21219Q48125220-C22BB8A8-1278-4892-A422-A6330C91FE4FQ52579561-974BA13F-6778-44B8-B908-DA3D07765748Q53381621-AC7DE7F5-61C5-4DCC-AE5B-6ABBEF76735DQ58712148-FFA17474-6249-4DAB-96AC-2FB1041EC707
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Apoptosis and Parkinson's disease.
@ast
Apoptosis and Parkinson's disease.
@en
type
label
Apoptosis and Parkinson's disease.
@ast
Apoptosis and Parkinson's disease.
@en
prefLabel
Apoptosis and Parkinson's disease.
@ast
Apoptosis and Parkinson's disease.
@en
P2093
P1476
Apoptosis and Parkinson's disease.
@en
P2093
Daniel Offen
Eldad Melamed
P304
P356
10.1016/S0278-5846(03)00019-8
P577
2003-04-01T00:00:00Z